Relapsed Non Hodgkin Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide1Recruiting1
DB01073Fludarabine1Recruiting1
DB00041Aldesleukin1 / 2Active Not Recruiting1
DB15699Brexucabtagene autoleucel1 / 2Recruiting1
DB00958Carboplatin1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00987Cytarabine1 / 2Recruiting1
DB01234Dexamethasone1 / 2Recruiting1
DB00099Filgrastim1 / 2Recruiting1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB15721Natural Killer Cell1 / 2Active Not Recruiting1
DB00073Rituximab1 / 2Active Not Recruiting1
DB00073Rituximab1 / 2Recruiting1
DB11581Venetoclax1 / 2Recruiting1
DB00026Anakinra2Not Yet Recruiting1
DB09312Antilymphocyte immunoglobulin (horse)2Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Recruiting1
DB13915Axicabtagene ciloleucel2Not Yet Recruiting1
DB00928Azacitidine2Not Yet Recruiting1
DB00091Cyclosporine2Recruiting1
DB00078Ibritumomab tiuxetan2Recruiting1
DB00688Mycophenolate mofetil2Recruiting1
DB00073Rituximab2Recruiting1
DB14922Tislelizumab2Recruiting1